RecruitingNCT07374861
Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy
Sponsor
Federico II University
Enrollment
1,500 participants
Start Date
Nov 4, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
Evaluation of adherence, persistence, and efficacy of treatment with Bempedoic acid in a real-life Italian population.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a drug called Bempedoic acid for people with hypercholesterolemia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGBempedoic acid
film-coated tablets
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07374861
Related Trials
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
NCT0747770434 locations
Causes and Natural History of Dyslipidemias
NCT003537821 location
Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
NCT0645177016 locations
A Post-Marketing Clinical Trial of Pemafibrate in Patients ｗith Hypercholesterolemia and Inadequate Response to Statins
NCT0763448410 locations
A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
NCT074045531 location